header
Image from OpenLibrary

Detection of c-x-c chemokine receptor type 5 gene polymorphisms in Egyptian non-hodgkin lymphoma patients / Lamees Mohamed Fathi ; Supervised Manal Mohamed Elmasry , Manal Mohamed Makhlouf , Eman Roshdy Radwan

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Lamees Mohamed Fathi , 2017Description: 198 p. : charts , facsimiles ; 25CMOther title:
  • الكشف عن تعدد الأشكال الوراثية لجين مستقيل ال سي-إكس سي أر - 5 فى مرضى سرطان الغدد الليمفاوية الغير هودجكين المصريين [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: The chemokine receptor CXCR5 is selectively expressed on B cells and it is involved in lymphocyte homing and the development of normal lymphoid tissue. Its principle ligand is CXCL13 or B lymphocyte chemoattractant (BLC). Three polymorphisms in CXCR5 gene, rs148351692 C/G, rs6421571 C/T, and rs78440425 G/A, have been identified in CXCR5 gene. The aim of the work is to study the expression and to assess the impact of genetic polymorphisms of CXCR5 on the susceptibility and response to therapy of non-Hodgkin lymphoma (NHL). Fifty patients with NHL as well as fifty healthy control subjects are included in this study. CXCR5 rs148351692 C/G, rs6421571 C/T, and rs78440425 G/A genotypes were determined by PCR-RFLP. Our study revealed that both CXCR5 rs148351692 C/G, rs6421571 C/T gene polymorphisms are associated with increased risk of developing NHL with OR=29.57 (95% CI=8.96-97.56) and 4.45 (95% CI=1.68-11.81) respectively, while CXCR5 rs78440425 G/A showed no statistical significant difference between NHL patients and the control group regarding the risk of developing NHL. Moreover, the double and triple combined gene polymorphisms are associated with about 129 fold and 108 fold respectively increased risk of developing NHL. In conclusion, CXCR5 rs148351692 C/G, rs6421571 C/T, and rs78440425 G/A gene polymorphisms could be involved in the pathophysiology and development of NHL. They may be useful as predictive molecular markers for prognosis and disease outcome in NHL patients
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.Ph.D.2017.La.D (Browse shelf(Opens below)) Not for loan 01010110074165000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.Ph.D.2017.La.D (Browse shelf(Opens below)) 74165.CD Not for loan 01020110074165000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

The chemokine receptor CXCR5 is selectively expressed on B cells and it is involved in lymphocyte homing and the development of normal lymphoid tissue. Its principle ligand is CXCL13 or B lymphocyte chemoattractant (BLC). Three polymorphisms in CXCR5 gene, rs148351692 C/G, rs6421571 C/T, and rs78440425 G/A, have been identified in CXCR5 gene. The aim of the work is to study the expression and to assess the impact of genetic polymorphisms of CXCR5 on the susceptibility and response to therapy of non-Hodgkin lymphoma (NHL). Fifty patients with NHL as well as fifty healthy control subjects are included in this study. CXCR5 rs148351692 C/G, rs6421571 C/T, and rs78440425 G/A genotypes were determined by PCR-RFLP. Our study revealed that both CXCR5 rs148351692 C/G, rs6421571 C/T gene polymorphisms are associated with increased risk of developing NHL with OR=29.57 (95% CI=8.96-97.56) and 4.45 (95% CI=1.68-11.81) respectively, while CXCR5 rs78440425 G/A showed no statistical significant difference between NHL patients and the control group regarding the risk of developing NHL. Moreover, the double and triple combined gene polymorphisms are associated with about 129 fold and 108 fold respectively increased risk of developing NHL. In conclusion, CXCR5 rs148351692 C/G, rs6421571 C/T, and rs78440425 G/A gene polymorphisms could be involved in the pathophysiology and development of NHL. They may be useful as predictive molecular markers for prognosis and disease outcome in NHL patients

Issued also as CD

There are no comments on this title.

to post a comment.